Stada Group
Volker S. is currently the EVP Global Consumer Health and a Member of the Executive Board at STADA Group, where Volker leads the Consumer Healthcare division. Prior to their current role, Volker held various senior positions at companies such as Namier Capital Partners, Tabletop, Sylphar nv, RB, SSL Healthcare International plc, and Unternehmensgruppe Theo Müller, demonstrating strong leadership and strategic skills in marketing and business development. In addition to their professional accomplishments, Volker S. has a solid educational background in Economics and International Marketing from institutions like Harvard Business School and the University of Strathclyde.
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.